13 results on '"Patrene KD"'
Search Results
2. Natural killer cell precursors in the CD44neg/dim T-cell receptor population of mouse bone marrow
- Author
-
Delfino, DV, primary, Patrene, KD, additional, Lu, J, additional, Deleo, A, additional, Deleo, R, additional, Herberman, RB, additional, and Boggs, SS, additional
- Published
- 1996
- Full Text
- View/download PDF
3. Purified murine hematopoietic stem cells function longer on nonirradiated W41/Wv than on +/+ irradiated stroma
- Author
-
Vecchini, F, primary, Patrene, KD, additional, and Boggs, SS, additional
- Published
- 1993
- Full Text
- View/download PDF
4. Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease.
- Author
-
D'Souza S, del Prete D, Jin S, Sun Q, Huston AJ, Kostov FE, Sammut B, Hong CS, Anderson JL, Patrene KD, Yu S, Velu CS, Xiao G, Grimes HL, Roodman GD, and Galson DL
- Subjects
- 3T3 Cells, Animals, Blotting, Western, Bone Marrow Cells metabolism, Bone Marrow Cells pathology, Bone Neoplasms genetics, Bone Neoplasms pathology, Cell Line, Tumor, Core Binding Factor Alpha 1 Subunit genetics, Core Binding Factor Alpha 1 Subunit metabolism, DNA-Binding Proteins genetics, Female, Gene Expression, Humans, Interleukin-7 metabolism, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Mice, SCID, Multiple Myeloma genetics, Multiple Myeloma pathology, Osteoblasts pathology, RNA Interference, Reverse Transcriptase Polymerase Chain Reaction, Stromal Cells pathology, Transcription Factors genetics, Tumor Necrosis Factor-alpha metabolism, Bone Neoplasms metabolism, DNA-Binding Proteins metabolism, Multiple Myeloma metabolism, Osteoblasts metabolism, Stromal Cells metabolism, Transcription Factors metabolism
- Abstract
Protracted inhibition of osteoblast (OB) differentiation characterizes multiple myeloma (MM) bone disease and persists even when patients are in long-term remission. However, the underlying pathophysiology for this prolonged OB suppression is unknown. Therefore, we developed a mouse MM model in which the bone marrow stromal cells (BMSCs) remained unresponsive to OB differentiation signals after removal of MM cells. We found that BMSCs from both MM-bearing mice and MM patients had increased levels of the transcriptional repressor Gfi1 compared with controls and that Gfi1 was a novel transcriptional repressor of the critical OB transcription factor Runx2. Trichostatin-A blocked the effects of Gfi1, suggesting that it induces epigenetic changes in the Runx2 promoter. MM-BMSC cell-cell contact was not required for MM cells to increase Gfi1 and repress Runx2 levels in MC-4 before OBs or naive primary BMSCs, and Gfi1 induction was blocked by anti-TNF-α and anti-IL-7 antibodies. Importantly, BMSCs isolated from Gfi1(-/-) mice were significantly resistant to MM-induced OB suppression. Strikingly, siRNA knockdown of Gfi1 in BMSCs from MM patients significantly restored expression of Runx2 and OB differentiation markers. Thus, Gfi1 may have an important role in prolonged MM-induced OB suppression and provide a new therapeutic target for MM bone disease.
- Published
- 2011
- Full Text
- View/download PDF
5. Osteoclasts are important for bone angiogenesis.
- Author
-
Cackowski FC, Anderson JL, Patrene KD, Choksi RJ, Shapiro SD, Windle JJ, Blair HC, and Roodman GD
- Subjects
- Angiogenesis Inducing Agents metabolism, Animals, Female, Fetus blood supply, Fetus drug effects, Humans, Male, Matrix Metalloproteinase 9 deficiency, Matrix Metalloproteinase 9 genetics, Matrix Metalloproteinase 9 metabolism, Metatarsal Bones drug effects, Metatarsal Bones embryology, Mice, Mice, Inbred C57BL, Models, Biological, Osteoclasts drug effects, Osteoclasts enzymology, Parathyroid Hormone-Related Protein pharmacology, RANK Ligand pharmacology, Skull cytology, Skull drug effects, Skull enzymology, Up-Regulation drug effects, Metatarsal Bones blood supply, Neovascularization, Physiologic drug effects, Osteoclasts physiology
- Abstract
Increased osteoclastogenesis and angiogenesis occur in physiologic and pathologic conditions. However, it is unclear if or how these processes are linked. To test the hypothesis that osteoclasts stimulate angiogenesis, we modulated osteoclast formation in fetal mouse metatarsal explants or in adult mice and determined the effect on angiogenesis. Suppression of osteoclast formation with osteoprotegerin dose-dependently inhibited angiogenesis and osteoclastogenesis in metatarsal explants. Conversely, treatment with parathyroid hormone related protein (PTHrP) increased explant angiogenesis, which was completely blocked by osteoprotegerin. Further, treatment of mice with receptor activator of nuclear factor-kappaB ligand (RANKL) or PTHrP in vivo increased calvarial vessel density and osteoclast number. We next determined whether matrix metalloproteinase-9 (MMP-9), an angiogenic factor predominantly produced by osteoclasts in bone, was important for osteoclast-stimulated angiogenesis. The pro-angiogenic effects of PTHrP or RANKL were absent in metatarsal explants or calvaria in vivo, respectively, from Mmp9(-/-) mice, demonstrating the importance of MMP-9 for osteoclast-stimulated angiogenesis. Lack of MMP-9 decreased osteoclast numbers and abrogated angiogenesis in response to PTHrP or RANKL in explants and in vivo but did not decrease osteoclast differentiation in vitro. Thus, MMP-9 modulates osteoclast-stimulated angiogenesis primarily by affecting osteoclasts, most probably by previously reported migratory effects on osteoclasts. These results clearly demonstrate that osteoclasts stimulate angiogenesis in vivo through MMP-9.
- Published
- 2010
- Full Text
- View/download PDF
6. Fetal liver cells transplanted in utero rescue the osteopetrotic phenotype in the oc/oc mouse.
- Author
-
Tondelli B, Blair HC, Guerrini M, Patrene KD, Cassani B, Vezzoni P, and Lucchini F
- Subjects
- Animals, Crosses, Genetic, DNA Primers, Disease Models, Animal, Female, Fetus, Genotype, Humans, Mice, Mice, Inbred C57BL, Mice, Inbred Strains, Osteopetrosis embryology, Osteopetrosis pathology, Phenotype, Polymerase Chain Reaction, Pregnancy, Fetal Tissue Transplantation, Hematopoietic Stem Cell Transplantation, Liver Transplantation, Mutation, Osteopetrosis genetics, Osteopetrosis surgery, Vacuolar Proton-Translocating ATPases genetics
- Abstract
Autosomal recessive osteopetrosis (ARO) is a group of genetic disorders that involve defects that preclude the normal function of osteoclasts, which differentiate from hematopoietic precursors. In half of human cases, ARO is the result of mutations in the TCIRG1 gene, which codes for a subunit of the vacuolar proton pump that plays a fundamental role in the acidification of the cell-bone interface. Functional mutations of this pump severely impair the resorption of bone mineral. Although postnatal hematopoietic stem cell transplantation can partially rescue the hematological phenotype of ARO, other stigmata of the disease, such as secondary neurological and growth defects, are not reversed. For this reason, ARO is a paradigm for genetic diseases that would benefit from effective prenatal treatment. Using the oc/oc mutant mouse, a murine model whose osteopetrotic phenotype closely recapitulates human TCIRG1-dependent ARO, we report that in utero transplantation of adult bone marrow hematopoietic stem cells can correct the ARO phenotype in a limited number of mice. Here we report that in utero injection of allogeneic fetal liver cells, which include hematopoietic stem cells, into oc/oc mouse fetuses at 13.5 days post coitum produces a high level of engraftment, and the oc/oc phenotype is completely rescued in a high percentage of these mice. Therefore, oc/oc pathology appears to be particularly sensitive to this form of early treatment of the ARO genetic disorder.
- Published
- 2009
- Full Text
- View/download PDF
7. Characterization of the stage in natural killer cell development in 14.5-day mouse fetal liver using adult bone marrow stroma.
- Author
-
Lu J, Patrene KD, Appasamy PM, Herberman RB, and Boggs SS
- Subjects
- Animals, Cell Differentiation, Cell Division, Culture Media, Conditioned, Flow Cytometry, Interleukin-15 pharmacology, Interleukin-2 pharmacology, Killer Cells, Natural immunology, Mice, Mice, Inbred C57BL, Stem Cell Factor pharmacology, Stem Cells cytology, Bone Marrow Cells physiology, Gestational Age, Killer Cells, Natural cytology, Liver cytology, Liver embryology, Stromal Cells physiology
- Abstract
Nonstimulated fetal liver (FL) from 14.5-day gestation mice had no natural killer (NK) cell activity and <3% expressed NK1.1. Even after short-term (3-4 day) culture of FL with the late-acting cytokines, interleukin (IL)-15 or IL-2, little or no NK activity was detected. However, longer-term (13 day) culture with IL-2 plus stroma derived from bone marrow (BM) of adult mice, resulted in extensive proliferation and differentiation to mature NK cells. Cell numbers began to increase after 4 days, and by day 13, they had increased 40-fold and 69% of the cells were NK1.1+ with high NK activity and 5%-10% were NK1.1- B220+. With stroma, but no IL-2, equivalent proliferation occurred, but differentiated cells were predominantly NK1.1- B220+, not NK cells. Culture for 13 days without stroma, but with either IL-2, IL-15, FLTK3-ligand (L) or stroma-conditioned medium, resulted in less than fivefold expansion, and minimal NK activity. Culture with combinations of FLTK3-L or ckit-L plus IL-15 or IL-2 increased both cell number and NK activity, but the increase in cell number was less than that seen with stroma plus IL-2. By limiting dilution assay on stroma plus IL-2, the precursor frequency was 1/(2660+/-292) whole FL cells and the absolute number, but not the frequency, increased during culture on stroma without IL-2. The NK cell progenitors were found in sorted NK1.1- and Sca-1+ c-kit+ lineage- subpopulations at a frequency of 1/(156+/-52.5). Together, these data suggest that the NK lineage cells in FL are primarily in early stages of development. They are highly proliferative, respond to early acting cytokines and express stem cell markers.
- Published
- 1999
- Full Text
- View/download PDF
8. Bone marrow as a potential source of hepatic oval cells.
- Author
-
Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, Boggs SS, Greenberger JS, and Goff JP
- Subjects
- 2-Acetylaminofluorene pharmacology, Animals, Bone Marrow Transplantation, Carbon Tetrachloride pharmacology, Cell Differentiation, Cell Division, DNA-Binding Proteins genetics, Dipeptidyl Peptidase 4 metabolism, Epithelial Cells cytology, Female, Hematopoietic Stem Cells cytology, In Situ Hybridization, Liver drug effects, Liver physiology, Liver Transplantation, Male, Polymerase Chain Reaction, Rats, Rats, Inbred F344, Rats, Inbred Lew, Sex-Determining Region Y Protein, Y Chromosome, Bone Marrow Cells cytology, Liver cytology, Liver Regeneration, Nuclear Proteins, Stem Cells cytology, Transcription Factors
- Abstract
Bone marrow stem cells develop into hematopoietic and mesenchymal lineages but have not been known to participate in production of hepatocytes, biliary cells, or oval cells during liver regeneration. Cross-sex or cross-strain bone marrow and whole liver transplantation were used to trace the origin of the repopulating liver cells. Transplanted rats were treated with 2-acetylaminofluorene, to block hepatocyte proliferation, and then hepatic injury, to induce oval cell proliferation. Markers for Y chromosome, dipeptidyl peptidase IV enzyme, and L21-6 antigen were used to identify liver cells of bone marrow origin. From these cells, a proportion of the regenerated hepatic cells were shown to be donor-derived. Thus, a stem cell associated with the bone marrow has epithelial cell lineage capability.
- Published
- 1999
- Full Text
- View/download PDF
9. Expression of murine CD34 by fetal liver NK cell progenitors.
- Author
-
Lu J, Patrene KD, Herberman RB, and Boggs SS
- Subjects
- Animals, Antigens, CD34, Cell Differentiation, Fetus physiology, Flow Cytometry, Hematopoiesis, Hematopoietic Stem Cells physiology, Humans, Liver physiology, Mice, Mice, Inbred C57BL, Fetus cytology, Hematopoietic Stem Cells cytology, Killer Cells, Natural cytology, Liver cytology
- Abstract
Although 14.5-day murine fetal liver (FL) has few, if any, mature natural killer (NK) cells, culture of FL with recombinant human IL-2 (rhIL-2) and stroma from irradiated NK longterm bone marrow cultures (NK-LTBMC) allows proliferation and differentiation of NK cell progenitors. Using this system, NK cell progenitors were found in both CD34+ and CD34- sorted subpopulations of FL. The CD34 antigen was expressed by 14+/-1.3% of whole FL cells, while mature NK cells cultured from NK cell precursors in FL did not express the CD34 antigen. Anti-TER-119 mAb reacted with 84%+/-10.3% of the FL cells, and NK cell progenitors were enriched in the TER-119- subpopulation. After coculture with rhIL-2 and stroma, neither TER-119- nor TER-119+ cells expressed antigens associated with T cells (CD3, CD4, and CD8) or myeloid cells (Gr-1 and Mac-1). Only the TER-119 subpopulation generated NK1.1+ (77%) and B220+ (87%) cells. Within the TER-119 subpopulation, both CD34+ and CD34- cells generated cytolytic and NK1.1+ cells after culture. By a limiting dilution assay (LDA) of the Lin (i.e., negative for NK1.1, CD3, CD4, CD8, B220, Gr-1, and TER-119) CD34 positive or negative subpopulations, the calculated mean frequency of NK cell progenitors was about 1/100 for the CD34+Lin- subpopulation and about 1/(200-300) for the CD34-Lin- subpopulation. In kinetic studies, we found that NK1.1 antigen expression continued to increase with time in culture for both the CD34+Lin- and CD34-Lin- fractions. In contrast, the percentage of CD34+ cells decreased rapidly and produced CD34- cells, and the CD34- population remained CD34-. These data suggest that both CD34+ and CD34- subpopulations of FL can differentiate into NK cells when cocultured for 13 days with irradiated NK-LTBMC stroma and rhIL-2, and that CD34+ progenitors differentiate to CD34- precursors, which in turn differentiate to CD34- mature NK cells.
- Published
- 1999
- Full Text
- View/download PDF
10. Hematopoiesis and aging III: Anemia and a blunted erythropoietic response to hemorrhage in aged mice.
- Author
-
Boggs DR and Patrene KD
- Subjects
- Anemia blood, Animals, Blood Volume, Body Weight, Erythrocyte Aging, Female, Hematocrit, Iron metabolism, Male, Mice, Mice, Inbred Strains, Aging, Anemia etiology, Erythropoiesis, Hemorrhage blood
- Abstract
Whether the hematocrit normally declines in the aged or whether such a decline represents inapparent disease in addition to aging is a matter of dispute. Female B6D2f1 mice were studied at ages 3, 13, or 27-28 months, and there was no difference in hematocrit between the younger groups. The hematocrit of 45 aged mice was slightly lower than that of 66 younger mice; mean 43% vs 49% (p less than .001). However, rather unexpectedly, the total red cell mass was not decreased in the aged; rather, the plasma volume was expanded. Survival of mature red blood cells did not differ significantly between young and aged mice. Mice were bled 0.4 ml from the orbital sinus for 4 days, reducing the hematocrit of all groups to a nadir of 20-25%. Recovery of hematocrit began more slowly in aged than in young mice. That this reflected a difference in erythropoiesis rather than a difference in plasma volume equilibration was suggested by studies with 59Fe. 59Fe was given following the second bleed, and 1 day later RBC 59Fe was more than twice as high in young mice than in groups of aged mice. Aged mice that did not appear healthy had been excluded. Aged mice were divided into a group with significant amounts of gray hair and/or patches of hair loss and two groups with normal-appearing hair; the latter was subdivided into those weighing less (25-26 g) or more (30-34 g) than most aged mice. Neither hair condition nor weight influenced hematocrit or response to bleeding. These results suggest, but do not prove, that a mild "dilutional" anemia and a blunted erythropoietic response to hemorrhage may be an expected part of the murine aging process.
- Published
- 1985
- Full Text
- View/download PDF
11. Murine recovery from busulfan-induced hematopoietic toxicity as assessed by three assays for colony-forming cells.
- Author
-
Boggs DR, Boggs SS, Chervenick PA, and Patrene KD
- Subjects
- Animals, Dose-Response Relationship, Drug, Erythropoiesis drug effects, Erythropoiesis radiation effects, Female, Hematocrit, Iron metabolism, Iron Radioisotopes, Male, Mice, Mice, Inbred C57BL, Mice, Inbred DBA, Radiation Chimera, Busulfan toxicity, Colony-Forming Units Assay, Hematopoiesis drug effects
- Published
- 1980
- Full Text
- View/download PDF
12. Marrow mass and distribution in murine skeletons cleaned by beetles as compared to cut up carcasses and a further simplification of the latter technique.
- Author
-
Boggs DR and Patrene KD
- Subjects
- Animals, Bone and Bones metabolism, Dissection methods, Female, Iron metabolism, Mice, Organ Size, Tissue Distribution, Anatomy methods, Bone Marrow anatomy & histology, Bone and Bones anatomy & histology, Coleoptera
- Abstract
Distribution of 59Fe into various bone groups of the complete murine skeleton was studied using two methods of dividing up the bones: 1) our previously reported technique of simply cutting up a skinned, eviscerated carcass and 2) separating bones from skeletons cleaned of overlying tissue by beetles, Dermestes species. The total percentage of injected 59Fe recovered in the sum of all skeletal parts, the percentage of total skeletal 59Fe found in each bone group, and the overall accuracy of determining these values were quite similar for the two techniques. The only statistically significant difference shown was a modest decrease in the percentage of total skeletal iron found in ribs plus sternum plus cervical and thoracic spine in beetle-cleaned as compared to cut up groups and we would not consider this to be of biological significance. Cutting up carcasses is the simpler of the two techniques but there are circumstances in which beetle digestion would be advantageous. In addition, we collected data on the reproducibility and precision of determining the percentage of 59Fe injected which is found in a "pulled off" foreleg plus scapula and of the distribution of 59Fe within three cut up pieces from the leg and within the scapula. These data can be used as a measure of overall changes in marrow mass and/or distribution, or at least they can be used as a screening procedure to detect such. This simple procedure adds potentially useful values for fully interpreting hematopoietic changes in the mouse.
- Published
- 1986
- Full Text
- View/download PDF
13. Alterations of nuclear size profiles in AKR/J mice with spontaneous or transplanted leukemia.
- Author
-
Schwartz GN, Patrene KD, and Boggs SS
- Subjects
- Animals, Blood Cells pathology, Female, Male, Mice, Mice, Inbred AKR, Neoplasm Transplantation, Thymus Gland cytology, Bone Marrow Cells, Cell Nucleus, Leukemia, Experimental pathology, Spleen cytology
- Abstract
Electronic sizing with a Coulter Counter was used to measure the frequency and number of cells with a large nuclear volume in tissues from AKR/J mice with spontaneous, long passaged, or first passage leukemia. The mean percentage of cells with a large nuclear volume was 1% in the blood, 4% in the spleen, 10% in the bone marrow, and 5% in the thymus of nonleukemic AKR/J mice. The percentage of cells with a large nucleus increased to 14-83% in all four tissues from AKR/J mice with spontaneous leukemia. In mice with a long passaged leukemia, a progressive increase in the percentage of cells with a large nucleus in the spleen and blood was associated with an increase in the number of cells/tissue with a large nucleus. However, in the bone marrow, an increase in percentage of cells with a large nuclear volume appeared to be the result of a decrease in the number of cells/humerus with a small nuclear volume. In the thymus, there was only a slight increase in the percentage of cells with a large nucleus. In mice with a first passage leukemia, there was a progressive increase, until death of the animals (21 +/- 1.9 days), in thymus weight and in the percentage of cells with a large nucleus. Also, the number of cells with a large nucleus increased in the spleen and bone marrow until day 12. Thereafter, there was a decrease in the total number of cells and number of cells with a large nucleus.
- Published
- 1983
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.